Alkermes
ALKS
#2326
Rank
$7.87 B
Marketcap
$46.85
Share price
3.08%
Change (1 day)
60.12%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): -$0.0000000000

According to Alkermes's latest financial reports the company's current EPS (TTM) is -$0.0000000000. In 2025 the company made an earnings per share (EPS) of $1.47 a decrease over its 2024 EPS that were of $2.23.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$0.0000000000-100%
2025$1.47-34.08%
2024$2.233.72%
2023$2.15-323.96%
2022-$0.96220%
2021-$0.30-57.19%
2020-$0.70-44.38%
2019-$1.26
2017-$1.03-24.82%
2016-$1.37-9.87%
2015-$1.52660%
2014-$0.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68-12,033,301,387,828,041,728.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$5.25-9,457,550,908,645,464,064.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.71-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$1.98-3,567,802,533,542,780,416.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
$4.52-8,142,500,972,776,666,112.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$7.12-12,826,240,470,391,560,192.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
-$50.31 90,630,359,278,848,245,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$0.45-810,647,220,741,039,744.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel